MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0105402
Hubra Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹13.56 Cr
▲ 10% YoY
Net profit · FY 2024
₹13.53 Lakh
Net margin 1%
EBITDA · FY 2024
₹55.51 Lakh
EBITDA margin 4.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹48.5 Lakh
Issued & subscribed
Open charges
₹3.06 Cr
Satisfied ₹1 Cr
Company age
10 yrs
Est. 2016
Employees · EPFO
20
Provident fund records
About Hubra Pharmaceuticals Private Limited
Data last updated:
Hubra Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2016PTC104726. Its GSTIN is 33AADCH8382G1ZI (Tamil Nadu).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹48.5 Lakh. It is led by directors including Pondavakkam Arunagirinathan Arunodhayan (Managing Director) and Pondavakkam Vijaya Arunagirinathan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.56 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹13.53 Lakh (net margin 1%) and EBITDA of ₹55.51 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 11% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Hubra Pharmaceuticals. As per MCA filings, the company has open charges of ₹3.06 Cr and satisfied charges of ₹1 Cr on record.
Hubra Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0105402). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hubra.in.
Company details
CIN U74900TN2016PTC104726
Registration Number 104726
Incorporation Date 17 March 2016
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0105402
Key People
Pondavakkam Arunagirinathan Arunodhayan Managing Director Pondavakkam Vijaya Arunagirinathan Director Pondahavakkam Arunodayan Priya Director Recognitions & Rankings of Hubra Pharmaceuticals
Contact details
Hubra Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is hubra.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNew No. 12/1 Old No. 22/1 Minor Trustpuram 1st Cross Street Trustpuram Kodambakka, M, Chennai, Tamil Nadu, India – 600024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hubra Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Hubra Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hubra Pharmaceuticals operates one associated brand: Hubra Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distribution of drugs, surgical disposables, and chemicals in South India. | hubra.in |
Business activity
The main business activity of Hubra Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hubra Pharmaceuticals Private Limited, buy the company report.
Financials of Hubra Pharmaceuticals Private Limited
FY 2025 filings availableHubra Pharmaceuticals Private Limited reported revenue of ₹13.56 Cr (up 10% YoY) for FY 2024.
Revenue · FY 2024
₹13.56 Cr ▲ 10%
Net profit · FY 2024
₹13.53 Lakh margin 1%
EBITDA · FY 2024
₹55.51 Lakh margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 16%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 27%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 10% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hubra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hubra Pharmaceuticals Private Limited
Hubra Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pondavakkam Vijaya Arunagirinathan | Director | 17 Mar 2016 | 10 Years 7 Months | Current |
| Pondavakkam Arunagirinathan Arunodhayan | Managing Director | 21 Apr 2016 | 10 Years 6 Months | Current |
| Pondahavakkam Arunodayan Priya | Director | 17 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
Hubra Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trinity Pharmaceuticals & Food Private Limited | ₹13.88 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Starus Pharmaceuticals Industries Private Limited | ₹13.72 Cr (FY 2023) | Manikonda, Telangana, India | ||||
| Hubra Pharmaceuticals Private Limitedthis company | ₹13.56 Cr (FY 2024) | ₹13.53 Lakh | 1% | 10.0% | 20 | Chennai, Tamil Nadu, India |
| Chemiker Pharmaceuticals Private Limited | ₹13.39 Cr (FY 2025) | 41.0% | Butibori, Maharashtra, India |
To see the full peer comparison of Hubra Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Hubra Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Hubra Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.06 Cr
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2020 | 100403844 | Hdfc Bank Limited | ₹3.06 Cr | Open | |
| 17 Sep 2018 | 100226743 | Indian Overseas Bank | ₹1 Cr | Satisfied |
To see the full charge records of Hubra Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Hubra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hubra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hubra Pharmaceuticals Private Limited has a workforce of 20 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
20
Active EPFO establishments
1
Employee growth
5.26%
GST
Hubra Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCH8382G1ZI | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hubra Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hubra Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Veerasamy Sanjeevikumar ceased to be Additional Director on 20 Jan 2017.
Charges
A charge with Hdfc Bank Limited of Rs. 305.98 Lakh registered on 15 Dec 2020 with Charge ID 100403844 was modified on 03 Oct 2025.
AGM
Hubra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hubra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 17 Sep 2018 via Charge ID 100226743 with Indian Overseas Bank was fully satisfied on 08 Mar 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 305.98 Lakh with Charge ID 100403844 was registered on 15 Dec 2020.
Charges
A charge with Indian Overseas Bank amounted to Rs. 100.00 Lakh with Charge ID 100226743 was registered on 17 Sep 2018.
Ceased
Veerasamy Sanjeevikumar ceased to be Additional Director.
Appointed
Pondavakkam Arunagirinathan Arunodhayan was appointed as Managing Director.
Appointed
Pondahavakkam Arunodayan Priya was appointed as Director.
Appointed
Pondavakkam Vijaya Arunagirinathan was appointed as Director.
Incorporation
17 Mar 2016
Hubra Pharmaceuticals Private Limited was registered on 17 Mar 2016 with Roc Chennai & aged 10 years 7 months as per MCA records.
Frequently asked questions
Hubra Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 March 2016 (10+ years old) and is registered under CIN U74900TN2016PTC104726.
Hubra Pharmaceuticals has 3 current directors:
- Pondavakkam Arunagirinathan Arunodhayan - Managing Director
- Pondavakkam Vijaya Arunagirinathan - Director
- Pondahavakkam Arunodayan Priya - Director
The latest financial statements of Hubra Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Hubra Pharmaceuticals is 33AADCH8382G1ZI, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Hubra Pharmaceuticals is U74900TN2016PTC104726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hubra Pharmaceuticals was incorporated on 17 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Hubra Pharmaceuticals by revenue are Trinity Pharmaceuticals & Food Private Limited, Starus Pharmaceuticals Industries Private Limited, Chemiker Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Veerasamy Sanjeevikumar ceased to be Additional Director on 20 Jan 2017. Pondavakkam Arunagirinathan Arunodhayan was appointed as Managing Director on 21 Apr 2016. Pondahavakkam Arunodayan Priya was appointed as Director on 17 Mar 2016. Hubra Pharmaceuticals has 4 board changes on record in total.
Yes, Hubra Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0105402).
Hubra Pharmaceuticals can be reached through the website hubra.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Hubra Pharmaceuticals is at New No. 121 Old No. 221 Minor Trustpuram 1st Cross Street Trustpuram Kodambakka, M, Chennai, Tamil Nadu, India – 600024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages